MARATTO

article · IEEE Access

Enhancing Chronic Disease Prediction in IoMT-Enabled Healthcare 5.0 Using Deep Machine Learning: Alzheimer’s Disease as a Case Study

202511 citationsOpen accessUniversity of Johannesburg

Abstract

Chronic disease significantly affects health on a global scale. Deep machine learning algorithms have found widespread application in the diagnosis of chronic diseases. Early diagnosis and treatment reduce the chance of a disease getting worse and, as a result, raise related mortality. The main objective of this work is to present a deep machine learning-based approach that provides better results in terms of accuracy. These findings have significance for tailored healthcare 5.0, enabling healthcare professionals to predict chronic disease more efficiently. A comparative examination of the most recent methods has been provided in our work reveals that it might be more advantageous to use the proposed model in which segmentation of the MRI is performed using U-net architecture and then classification is done using transfer learning for chronic disease prediction. Our proposed model provides 96.06% accuracy, it advances our understanding of deep machine learning’s potential for chronic disease prediction and emphasizes the need to tailor model selection to specific disease types using data from IoMT enabled devices. In order to make advanced improvement in the field of healthcare 5.0, future studies should focus on refining these models and investigating how well they work with a wider range of datasets.

Research topics

  • Brain Tumor Detection and Classification
  • Artificial Intelligence in Healthcare
  • Impact of AI and Big Data on Business and Society

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1109/access.2025.3525514

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.